Cell differentiation and therapeutic effect of low doses of cytosine arabinoside in human myeloid leukemia
- 1 January 1984
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 8 (5) , 783-790
- https://doi.org/10.1016/0145-2126(84)90099-7
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Does treatment with ARA-C in low dosage cause differentiation of leukemic cells?Blood, 1983
- Treatment of acute myelocytic leukemia with low-dose cytosine arabinoside: Results of a pilot study in four patientsLeukemia Research, 1983
- Small doses of ARA-C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells?British Journal of Haematology, 1982
- In vivo inhibition of the development of myeloid leukemia by injection of macrophage‐and granulocyte‐inducing proteinInternational Journal of Cancer, 1981
- Potential pre‐screening for therapeutic agents that induce differentiation in human myeloid leukemia cellsInternational Journal of Cancer, 1980
- Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL‐60) by compounds which induce differentiation of murine leukemia cellsInternational Journal of Cancer, 1980
- Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemiaNature, 1978
- Erythroleukemic DifferentiationAnnual Review of Biochemistry, 1978
- Control of lysozyme induction in the differentiation of myeloid leukemic cellsCell, 1976
- IN VITRO SYNTHESIS AND SECRETION OF LYSOZYME BY MONONUCLEAR PHAGOCYTESThe Journal of Experimental Medicine, 1974